|
|
|
![]() |
![]() |
|
||
Mason Lab Research: My research involves genetic engineering of plants for recombinant protein production and improved quality traits, with a major focus on vaccines. My lab also works on the regulation of plant gene expression and multimeric protein assembly, with the aim of optimizing accumulation of foreign proteins in plants, and the testing of plant-derived vaccines by oral delivery in model test animals. The research comprises 3 main categories: Plant-based vaccine production and testing. We use plants (potato, tomato, tobacco, alfalfa, and corn) as hosts for stable transformation and expression of vaccine antigens in edible tissues. Expression of foreign genes in plants may present challenging problems including transcription and mRNA processing, translation, assembly, and subcellular targeting. Since vaccine genes originate in diverse sources whose systems may be suboptimal for plant expression, we analyze coding sequences to identify potentially detrimental motifs that could mediate mRNA truncation or degradation, including polyadenylation signals, intron splice sites, and RNA instability motifs. We then use this information to design plant-optimized genes using plant-preferred codons. My lab has developed a number of useful expression cassettes using constitutive, chemically inducible, or tissue-specific promoters, viral translational enhancers, and efficient 3 elements, which we use routinely for antigen expression. After regeneration of the transgenic plant lines, we verify antigen expression and structure using specific immunoassays and biochemical characterization, then we use the edible material for animal trials to assess immunogenicity. Currently funded work in my laboratory includes development of plant-based vaccines for hepatitis B (NIH), human papillomavirus (NIH), Norwalk-like viruses (Japan Health Sciences Foundation), enteropathogenic E. coli (NIH), and plague (Department of Defense). Novel plant gene expression systems. We are investigating the use of plant geminivirus elements to enhance the expression of foreign proteins in a tightly regulated manner. High expression of foreign proteins often causes toxic effects in plant cells and may interfere with plant growth and development. Thus regulated expression is necessary in order to obtain the most efficient protein production. Incorporation of expression cassettes within viral replicons that can be replicated in trans by a viral factor (Rep) expressed from an inducible promoter yields high copy number of the cassette and maximizes the transcription. This work is currently supported by two grants from NSF for 1) use of geminivirus elements to enhance transient protein expression in plant cell and root cultures, and 2) stable expression of recombinant proteins in plant cell cultures using regulated geminivirus-mediated gene amplification. Multimeric protein assembly in plant cells. Using model vaccine antigens, we are investigating the synthesis, processing, and assembly of multimeric protein complexes in plants.
Selected publications, primary peer-reviewed: Judge NA, Mason HS, O'Brien AD (2004) Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect. Immun. 72:168-175. Huang Z, Mason HS (2004) Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. Plant Biotechnol. J., 2:241-249. Chikwamba RK, Scott MP, Mejia LB, Mason HS, Wang K (2003) Localization of a bacterial protein in starch granules of transgenic maize kernels. Proc. Natl. Acad. Sci. USA 100:11127-11132. Smith ML, Richter L,. Arntzen CJ, Shuler ML, Mason HS (2003) Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 21:4011-4021. Warzecha H, Mason HS, Lane C, Tryggvesson A, Rybicki E, Williamson A, Clements JD, Rose RC (2003) Oral immunogenicity of human papillomavirus-like particles expressed in potato. J. Virol 77:8702-8711. Sojikul P, Buehner N, Mason HS (2003) A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc. Natl. Acad. Sci. USA 100:2209-2214. Mor TS, Moon Y-S, Palmer KE, Mason HS (2003) Geminivirus vectors for high level expression of foreign proteins in plant cells. Biotechnol. Bioeng. 81: 430-437. Chikwamba R, McMurray J, Frame B, Scott P, Mason H, Wang K (2002). Expression of a bacterial antigen in maize: The role of regulatory sequences, inheritance and level of expression of the synthetic E. coli heat labile toxin B sub-unit (LT-B) in maize. Molecular Breeding 10: 253 - 263. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason HS, Wang K (2002). A functional antigen in a practical crop: Maize synthesized LT-B protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Research. 11:479-493. Smith ML, Mason HS, Shuler ML (2002) Hepatitis B surface antigen (HBsAg) expression in plant cell culture; the kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol. Bioeng. 80, 812-822. Kong Q, Richter L, Yang Y-F, Arntzen CJ, Mason HS, Thanavala Y (2001) Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 98:11539-11544. Mor TS, Sternfeld M, Soreq H, Arntzen CJ, Mason HS (2001) Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnol. Bioeng. 75: 259-266. Richter L, Thanavala Y, Arntzen CJ, Mason HS (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nature Biotechnol. 18:1167-1171. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182: 302-305. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in transgenic potato. Nature Medicine 4:607-609. Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against E. coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16:1336-1343. Mason HS, Ball J, Shi JJ, Jiang X, Estes MK, Arntzen CJ (1996) Expression and immunogenicity of Norwalk virus capsid protein from transgenic tobacco and potato. Proc. Natl. Acad. Sci. USA 93: 5335-5340. Thanavala Y, Yang Y-F, Lyons P, Mason HS, Arntzen C. (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 92:3358-3361. Haq TA, Mason HS, Clements JD, Arntzen CJ. (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714-716. Mason H, DeWald D, Mullet J. (1993) Identification of a methyl jasmonate responsive domain in the soybean vspB promoter. Plant Cell 5:241-251. Mason H, Lam D, Arntzen CJ. (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89:11745-11749. Selected publications, invited reviews: Mason HS, Chikwamba R, Santi L, Mahoney RT, Arntzen CJ (2004) Antigen delivery systems: Transgenic plants for mucosal vaccines. In: Mucosal Immunology, 3rd Edition. Section D. Mucosal Vaccines (McGhee JR, Mestecky JF, Eds) Elsevier Science, London. In press. Mason HS (2004) Vaccines produced in transgenic plants. In: Encyclopedia of Plant and Crop Science (Goodman RM, Ed.). Marcel Dekker, New York. In press. Mor TS, Mason HS, Kirk D, Arntzen CJ, Cardineau GA (2004) Plants as a delivery vehicle for orally delivered subunit vaccines. In: New Generation Vaccines, Third Edition (Levine M, Ed.), pp. 305-311. Marcel Dekker, New York. In press. Mor TS, Mason HS (2003) Plants as a source for subunit vaccines. In: Handbook of Plant Physiology (Christou P, Klee H, Eds.) John Wiley & Sons. In press. Mason HS, Warzecha H, Mor TS, Arntzen CJ (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med.8:324-329. Mason HS (2002) Plant-based vaccines: Expression and oral immunogenicity. In Vitro Cell. Devel. Biol. Plant 38:237-240. Tacket CO, Mason HS (1999) A review of oral vaccination with transgenic vegetables. Microbes & Infection 1:1-7. Mason HS, Arntzen CJ (1998) Edible vaccines -- the future for paediatric vaccines delivery? Vaccines: Children and Practice, 1:13-15. Arntzen CJ, Mason HS (1997) Oral vaccine production in the edible tissues of transgenic plants. In: New Generation Vaccines, Second Edition (Eds. Levine MM, Woodrow GC, Kaper JB, Cobon GS) Marcel Dekker, New York, Pages 263-277. Mason HS, Arntzen CJ (1995) Transgenic plants as vaccine production systems. Trends Biotechnol. 13:388-392.
Contact SOLS|ASU Accessibility|Contact Web Master ASU Accessibility|ASU Privacy ASU Copyright & Trademark Statement Copyright All Rights Reserved |
|